Peer Review History

Original SubmissionFebruary 10, 2022
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Attachments
Attachment
Submitted filename: ThyroidSHIP_ML_revised_with_changes.pdf
Decision Letter - Holger Fröhlich, Editor

PONE-D-22-03831Analysis of epidemiological association patterns of serum Thyrotropin by combining random forests and Bayesian networksPLOS ONE

Dear Dr. Kaderali,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised by the reviewers during the review process.

Please submit your revised manuscript by May 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Holger Fröhlich

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere.

(Full submission to PLOS Computational Biology, This is a transfer submission.) 

Please clarify whether this publication was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript " Analysis of epidemiological association patterns of serum Thyrotropin by combining random forests and Bayesian networks " presents a valuable and interesting approach to how two techniques can be combined to create predictive models. The work has been carried out with care and is presented in sufficient detail. The manuscript has been reviewed before and thereafter transferred to PlosONE. Reviser’s comments, re-comments by the authors and corrections in the text are contained in the submission. The editor comment on rejection was: ”While the reviewers do not find any major technical flaws that would preclude publication of the work, they also mark on the lack of depth of the manuscript and potential practical relevance”.

I agree with the editors statement, that there are no major technical flaws that would preclude publication. I disagree with the statement of “lack of depth of the manuscript and potential practical relevance”.

Main critics was given by previous reviewer #1 in two points:

a) He/she is missing a comparison with other existing methods … making this research of interests for the bioinformatics and ML community.

The reviewer's request is understandable but hardly realizable. There a plenty of ways how build reliable prediction models, especially if techniques are combines. Further, the generalization of any comparison lacks the scenarios simulated for it. The authors already present a simulation, showing that their approach picks out necessary features for prediction. They intensively applied cross validation, a well-accepted technique for robust model building.

b) The reviewer implicitly focus on ML models.

I understand the author’s aim of their approach is in improving prediction by combining methods, not stating that their approach is universal best. It goes without saying, that the concept can also be used if, for example, the Bayesian Network is replaced by a ML-prediction models.

c) Another point of critics was given by previous reviewer #2 regarding the practical value of predicting TSH levels from other blood-based variables, instead of directly measuring from blood.

A possible application of the presented results could be follows: A measured TSH level that exceeds the predicted value may raise medical concerns about finding the cause. Or: A predicted high TSH value should be verified by direct measurement. The application of the proposed results is not the scope of the manuscript.

All in all, I recommend the manuscript for publication without the need for further revision.

Reviewer #2: Notes:

1. The algorithm as outlined is reasonable but the approach is not entirely novel. The authors perform what's known as Markov Blanket feature selection before modeling the data with a Bayes Net. Indeed, it is somewhat unusual to perform BN fitting without prior variable selection on a large-enough dataset. For a similar example where SVMs are used to perform feature selection see, for example:

Shen et al, Markov Blanket Feature Selection for Support Vector Machines, AAAI, 2008

and for the theoretical justification of this type of a first-pass filter see this foundational paper:

Koller and Sahami, Toward Optimal Feature Selection, ICML, 1996

This comment should be interpreted as a suggestion for a useful reference or two, which would help build the context for the work, but does not invalidate the technical accuracy or practical utility of the authors' approach. Please consider this as a request for a very minor revision.

2. Please note in the Results and Discussion paper that all of the algorithm details are specified in the Methods section. While that's a reasonable place to expect those things to be, and while the level of detail in that section is adequate, the paper is sufficiently technical that I've asked myself what the RF- and BN-fitting details might be at least 20 times before finally reaching the methods section. It might even be worth it to invest a sentence per algorithm to give at least a high-level outline of the methods the first time they are mentioned in Results.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Albert Rosenberger

Reviewer #2: Yes: Boris Hayete

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We thank the reviewers for their positive feedback. Please see the "Response to Reviewers" letter for a detailed response to the individual points raised.

Attachments
Attachment
Submitted filename: ResponseToReviewers.pdf
Decision Letter - Holger Fröhlich, Editor

Analysis of epidemiological association patterns of serum Thyrotropin by combining random forests and Bayesian networks

PONE-D-22-03831R1

Dear Dr. Kaderali,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Holger Fröhlich

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Holger Fröhlich, Editor

PONE-D-22-03831R1

Analysis of epidemiological association patterns of serum Thyrotropin by combining random forests and Bayesian networks

Dear Dr. Kaderali:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Dr. Holger Fröhlich

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .